4/22
04:22 pm
enta
ArriVent Appoints Kristine Peterson to its Board of Directors [Yahoo! Finance]
Low
Report
ArriVent Appoints Kristine Peterson to its Board of Directors [Yahoo! Finance]
4/17
07:12 am
enta
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024 [Yahoo! Finance]
Medium
Report
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024 [Yahoo! Finance]
4/17
07:00 am
enta
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Medium
Report
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
4/6
02:04 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/29
11:08 pm
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/6
07:00 am
enta
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
Medium
Report
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
2/12
06:35 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report [Yahoo! Finance]
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report [Yahoo! Finance]
2/8
10:05 pm
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/8
05:53 pm
enta
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at JPMorgan Chase & Co. from $12.00 to $11.00. They now have an "underweight" rating on the stock.
Low
Report
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at JPMorgan Chase & Co. from $12.00 to $11.00. They now have an "underweight" rating on the stock.
2/8
09:25 am
enta
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
2/7
05:10 pm
enta
Enanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ... [Yahoo! Finance]
Medium
Report
Enanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ... [Yahoo! Finance]
2/7
04:16 pm
enta
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET [Yahoo! Finance]
Low
Report
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET [Yahoo! Finance]
2/7
04:01 pm
enta
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
Medium
Report
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
2/6
07:00 am
enta
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Low
Report
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
1/31
07:12 am
enta
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023 [Yahoo! Finance]
Low
Report
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023 [Yahoo! Finance]
1/31
07:00 am
enta
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
Low
Report
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023